Literature DB >> 19408343

Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.

Ruo-Chia Tseng1, Feng-Jen Hsieh, Chuen-Ming Shih, Han-Shui Hsu, Chih-Yi Chen, Yi-Ching Wang.   

Abstract

BACKGROUND: Nonsmall cell lung cancer (NSCLC) frequently exhibits genomic instability, such as high fractional allelic loss (FAL). Genomic instability may result from unrepaired or misrepaired double-strand breaks (DSBs). The authors of this report postulated that polymorphisms in genes of the nonhomologous end-joining (NHEJ) pathway, which is the major DSB repair pathway in mammalian cells, may modulate lung cancer susceptibility and prognosis.
METHODS: Patients with NSCLC (n = 152) and a group of appropriate age-matched and sex-matched controls (n = 162) were subjected to genotype analysis of the NHEJ pathway genes x-ray repair complementing defective repair in Chinese hamster cells 6 (Ku70) (reference single nucleotide polymorphism number [rs] 2267437), x-ray repair complementing defective repair in Chinese hamster cells 5 (Ku80) (rs3835), x-ray repair complementing defective repair in Chinese hamster cells 4 (XRCC4) (rs1805377), and DNA ligase IV (LIG4) (rs1805388). The gene-gene interaction (joint effect), genotype-environmental (ie, smoking) correlation, and genotype-phenotype (ie, FAL) correlation were examined. The Kaplan-Meier method and log-rank tests were used to assess the prognostic effect.
RESULTS: There was a significant association between the XRCC4 and LIG4 genotypes with NSCLC risk in an analysis of individual polymorphism associations, and the risk of NSCLC increased further in a combined analysis of multiple polymorphisms (adjusted odds ratio [OR], 8.74). The patients who had a homozygous variant guanine/guanine genotype of the XRCC4 gene had a poorer prognosis compared with other patients (P = .015). There was a significant difference between the patient smokers and controls for XRCC4 (adjusted OR, 2.67) and LIG4 (adjusted OR, 2.04). In addition, polymorphisms in XRCC4 and LIG4 were linked significantly with patients who had high FAL (adjusted OR, 2.03-3.84).
CONCLUSIONS: To the authors' knowledge, this is the first nested case-control study to demonstrate a significant association between the polymorphisms of genes in the NHEJ pathway and lung cancer susceptibility and prognosis. The results may be useful for risk assessment and disease monitoring of patients with NSCLC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19408343     DOI: 10.1002/cncr.24327

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism.

Authors:  Sheetal Sharma; Bibha Choudhary; Sathees C Raghavan
Journal:  Cell Mol Life Sci       Date:  2010-08-03       Impact factor: 9.261

2.  Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.

Authors:  L A Henríquez-Hernández; A Valenciano; P Foro-Arnalot; M J Álvarez-Cubero; J M Cozar; J F Suárez-Novo; M Castells-Esteve; P Fernández-Gonzalo; B De-Paula-Carranza; M Ferrer; F Guedea; G Sancho-Pardo; J Craven-Bartle; M J Ortiz-Gordillo; P Cabrera-Roldán; J I Rodríguez-Melcón; E Herrera-Ramos; C Rodríguez-Gallego; P C Lara
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

Review 3.  Genetic intersection of male infertility and cancer.

Authors:  Liina Nagirnaja; Kenneth I Aston; Donald F Conrad
Journal:  Fertil Steril       Date:  2018-01       Impact factor: 7.329

4.  Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice.

Authors:  Jian Ye; Zhenyi Ren; Qing Gu; Limin Wang; Jiaoli Wang
Journal:  DNA Cell Biol       Date:  2011-06-11       Impact factor: 3.311

5.  Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk.

Authors:  Hong Jiang; Yun Lin; Chang-qing Yang; Qi Li; Jinhong Luo; Ying Zhou; Junli Xue; Wei Wei; Yong Gao
Journal:  Tumour Biol       Date:  2012-12-28

6.  Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.

Authors:  Ming Yin; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Michael O'Reilly; Daniel Gomez; Minghuan Li; Ritsuko Komaki; Qingyi Wei
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

7.  The Ku70 -1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population.

Authors:  Wenshan He; Sijia Luo; Tao Huang; Jinghua Ren; Xiaoling Wu; Jun Shao; Qingyao Zhu
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

Review 8.  Association between the XRCC6 Promoter rs2267437 polymorphism and cancer risk: evidence based on the current literature.

Authors:  Haitao Xu; Peng Zou; Pin Chen; Lin Zhao; Peng Zhao; Ailin Lu
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-08

9.  Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy.

Authors:  Amrita Singh; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Mol Biol Rep       Date:  2018-02-03       Impact factor: 2.316

10.  Ovarian cancer and DNA repair: DNA ligase IV as a potential key.

Authors:  Joana Assis; Deolinda Pereira; Rui Medeiros
Journal:  World J Clin Oncol       Date:  2013-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.